TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PharmaLex Sweden AB
Closing information (x1000 DKK)
Closing information | 2023/09 | 2022/12 | 2021/12 |
Turnover |
17,990
|
17,893
|
12,618 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
266
|
1,808
|
869 |
EBITDA |
270
|
1,820
|
881 |
Total assets |
6,446
|
6,210
|
5,163 |
Current assets |
6,420
|
6,175
|
5,114 |
Current liabilities |
4,740
|
3,653
|
3,937 |
Equity capital |
1,706
|
2,557
|
1,226 |
- share capital |
65
|
67
|
73 |
Employees (average) |
12
|
11
|
9 |
Financial ratios
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Solvency |
26.5%
|
41.2%
|
23.7% |
Turnover per employee |
1,499
|
1,627
|
1,402 |
Profit as a percentage of turnover |
1.5%
|
10.1%
|
6.9% |
Return on assets (ROA) |
4.1%
|
29.1%
|
16.8% |
Current ratio |
135.4%
|
169.0%
|
129.9% |
Return on equity (ROE) |
15.6%
|
70.7%
|
70.9% |
Change turnover |
616
|
6,297
|
2,499 |
Change turnover % |
4%
|
54%
|
25% |
Chg. No. of employees |
1
|
2
|
1 |
Chg. No. of employees % |
9%
|
22%
|
13% |
Total value of public sale
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.